Positron emission tomography probes for imaging immune activation and selected cancers
Patent
·
OSTI ID:1034633
- Los Angeles, CA
Compounds for use as PET probes and methods for synthesizing and using these, comprising [.sup.18F]D-FAC and other cytosine and adenosine analogs.
- Research Organization:
- Univ. of California, Oakland, CA (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- FG02-06ER64249
- Assignee:
- The Regents of the University of California (Oakland, CA)
- Patent Number(s):
- 8,101,740
- Application Number:
- 12/234,478
- OSTI ID:
- 1034633
- Country of Publication:
- United States
- Language:
- English
Similar Records
Positron emission tomography probe to monitor selected sugar metabolism in vivo
Positron-labeled angiotensin-converting enzyme (ACE) inhibitor: Fluorine-18-fluorocaptopril. Probing the ACE activity in vivo by positron emission tomography
WE-G-BRD-06: Variation in Dynamic Positron Emission Tomography Imaging of Tumor Hypoxia in Early Stage Non-Small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy
Patent
·
Tue Mar 14 00:00:00 EDT 2017
·
OSTI ID:1034633
+2 more
Positron-labeled angiotensin-converting enzyme (ACE) inhibitor: Fluorine-18-fluorocaptopril. Probing the ACE activity in vivo by positron emission tomography
Journal Article
·
Sun Sep 01 00:00:00 EDT 1991
· Journal of Nuclear Medicine; (United States)
·
OSTI ID:1034633
+3 more
WE-G-BRD-06: Variation in Dynamic Positron Emission Tomography Imaging of Tumor Hypoxia in Early Stage Non-Small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy
Journal Article
·
Sun Jun 15 00:00:00 EDT 2014
· Medical Physics
·
OSTI ID:1034633
+8 more